COLLEGIUM PHARMACEUTICAL, INC·4

Mar 19, 4:36 PM ET

Dieter David 4

4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Mar 19, 2025

Insider Transaction Report

Form 4
Period: 2025-03-17
Dieter David
EVP & General Counsel
Transactions
  • Award

    Common Stock

    2025-03-17+68,44968,449 total
Footnotes (1)
  • [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Thirty-three percent (33%) of the RSUs shall vest on March 17, 2026, with the balance vesting in two annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES